Drug profile · INN
daptomycin
CUBICIN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
daptomycin (CUBICIN) is an FDA-listed pharmaceutical active ingredient. Associated with MAIA Biotechnology. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN daptomycin
Brand CUBICIN
Route INTRAVENOUS
Formulation POWDER
ATC code J01XX09
Originator MAIA Biotechnology
Frequently asked questions
What is daptomycin?
daptomycin (CUBICIN) is an FDA-listed pharmaceutical active ingredient. Associated with MAIA Biotechnology. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for daptomycin?
CUBICIN is a marketed brand name for daptomycin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of daptomycin?
daptomycin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.